Equity Overview
Price & Market Data
Price: $28.78
Daily Change: -$0.35 / 1.22%
Daily Range: $28.18 - $29.72
Market Cap: $21,180,833,792
Daily Volume: 2,239,599
Performance Metrics
1 Week: 6.98%
1 Month: 24.05%
3 Months: 17.85%
6 Months: 38.31%
1 Year: 173.8%
YTD: 59.82%
Company Details
Employees: 159
Sector: Health technology
Industry: Biotechnology
Country:
Details
Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis, as well as in Phase III clinical trials for the treatment of non-small lung cancer. The company was founded in 2003 and is headquartered in Miami, Florida.